Gender differences in treatment of cardiovascular disease: A task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology

Fundamental and Clinical Pharmacology

Volumn 24, Issue 6, 2010, Pages 662-663

  Rosano, Giuseppe M C ^a   Collins, Peter ^b  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; SEX HORMONE; VALSARTAN;

ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; EDITORIAL; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE;

CARDIOVASCULAR DISEASES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; RISK FACTORS; SEX FACTORS;

EID: 78349271737     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00895_2.x     Document Type: Editorial

References (17)

1. Straface E., Gambardella L., Metere A. et al. Oxidative stress and defective platelet apoptosis in naïve patients with Kawasaki disease. Biochem. Biophys. Res. Commun. (2010) 392 426-430.
2. Pierdominici M., Maselli A., Colasanti T. et al. Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol. Lett. (2010) 132 79-85.
3. Straface E., Vona R., Gambardella L. et al. Cell sex determines anoikis resistance in vascular smooth muscle cells. FEBS Lett. (2009) 583 3448-3454.
4. Traish A.M., Kypreos K.E. Testosterone and cardiovascular disease: an old idea with modern clinical implications. Atherosclerosis 2010, [Epub ahead of print].
5. Nedungadi T.P., Clegg D.J. Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J Cardiovasc Transl Res. (2009) 2(3) 321-327 [Epub 2009 Apr 23].
6. Vitale C., Mendelsohn M.E., Rosano G.M. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol. (2009) 6 532-542.
7. Kang S., Fan H.M., Li J., Fan L.Y., Miao A.Y., Bao Y., Wu L.Z., Zhu Y., Zhang D.F., Liu Z.M. Relationship of arterial stiffness and early mild diastolic heart failure in general middle and aged population. Eur Heart J. 2010 [Epub ahead of print].
8. Juhász M., Katona E., Settakis G. et al. Gender-related differences in adolescent hypertension and in target organ effects. J Womens Health (2010) 19 759-765.
9. Szymański P., Klisiewicz A., Lubiszewska B. et al. Gender differences in angiotensin II and aldosterone secretion in patients with pressure overloaded systemic right ventricles are similar to those observed in systemic arterial hypertension. Int. J. Cardiol. (2009), [Epub ahead of print].
10. Tuomilehto J. Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly. Am. J. Med. (1991) 90 34S-41S.
11. Mercuro G., Deidda M., Piras A., Dessalvi C.C., Maffei S., Rosano G.M. Gender determinants of cardiovascular risk factors and diseases. J Cardiovasc Med. (2010) 11 207-220.
12. Vitale C., Miceli M., Rosano G.M. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric (2007) 10(Suppl 2) 16-20.
13. Collins P., Rosano G., Casey C. et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur. Heart J. (2007) 28 2028-2040.
14. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet (1996) 348 1339-1342.
15. Zanchetti A., Julius S., Kjeldsen S. et al. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial. J. Hypertens. (2006) 24 2163-2168.
16. Julius S., Weber M.A., Kjeldsen S.E. et al. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension (2006) 48 385-391.
17. Parker B.A., Kalasky M.J., Proctor D.N. Evidence for sex differences in cardiovascular aging and adaptive responses to physical activity. Eur J ApplPhysiol. (2010) 110(2) 235-46.